• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大鼠纹状体中的芳香族L-氨基酸脱羧酶:对左旋多巴在帕金森病中作用的启示。

Aromatic L-amino acid decarboxylase in rat corpus striatum: implications for action of L-dopa in parkinsonism.

作者信息

Melamed E, Hefti F, Pettibone D J, Liebman J, Wurtman R J

出版信息

Neurology. 1981 Jun;31(6):651-5. doi: 10.1212/wnl.31.6.651.

DOI:10.1212/wnl.31.6.651
PMID:7195482
Abstract

We studied the distribution of aromatic L-amino acid decarboxylase (AAAD) activity in striatal compartments of rats. After near-total destruction of nigrostriatal dopaminergic neurons, 15 to 20% of the initial enzyme activity remained. Striatal enzyme activity remained unchanged after destruction of serotoninergic terminals by electrolytic raphe lesions. Combined raphe-nigrostriatal lesions or nigrostriatal lesions alone produced similar decreases in striatal decarboxylase. Intrastriatal injection of kainic acid (which selectively destroys striatal interneurons and efferent neurons and also induces marked glial proliferation) reduced activity by 20%. Only 7% of initial striatal activity (perhaps localized in capillaries) remained after combined nigrostriatal-kainic acid lesions. These findings indicate that after degeneration of dopaminergic terminals, striatal interneurons and efferent neurons, but not serotonergic terminals of glia, contain an important fraction of the residual AAAD. This compartment may be the site of enzymatic conversion of exogenous L-dopa to dopamine in the parkinsonian striatum.

摘要

我们研究了大鼠纹状体各部分中芳香族L-氨基酸脱羧酶(AAAD)活性的分布。黑质纹状体多巴胺能神经元几乎完全被破坏后,仍保留了15%至20%的初始酶活性。通过电解中缝核损伤破坏5-羟色胺能终末后,纹状体酶活性保持不变。联合中缝核-黑质纹状体损伤或单独的黑质纹状体损伤导致纹状体脱羧酶出现类似程度的降低。纹状体内注射 kainic 酸(它选择性地破坏纹状体中间神经元和传出神经元,并诱导明显的胶质细胞增殖)使活性降低了20%。黑质纹状体-kainic 酸联合损伤后,仅保留了7%的初始纹状体活性(可能定位于毛细血管)。这些发现表明,在多巴胺能终末、纹状体中间神经元和传出神经元变性后,但不是胶质细胞的5-羟色胺能终末,含有残余AAAD的重要部分。这个部分可能是帕金森病纹状体中外源性左旋多巴酶促转化为多巴胺的部位。

相似文献

1
Aromatic L-amino acid decarboxylase in rat corpus striatum: implications for action of L-dopa in parkinsonism.大鼠纹状体中的芳香族L-氨基酸脱羧酶:对左旋多巴在帕金森病中作用的启示。
Neurology. 1981 Jun;31(6):651-5. doi: 10.1212/wnl.31.6.651.
2
Nonaminergic striatal neurons convert exogenous L-dopa to dopamine in parkinsonism.非胺能纹状体神经元在帕金森病中将外源性左旋多巴转化为多巴胺。
Ann Neurol. 1980 Dec;8(6):558-63. doi: 10.1002/ana.410080603.
3
Localization and functional significance of striatal neurons immunoreactive to aromatic L-amino acid decarboxylase or tyrosine hydroxylase in rat Parkinsonian models.大鼠帕金森病模型中对芳香族L-氨基酸脱羧酶或酪氨酸羟化酶免疫反应阳性的纹状体神经元的定位及功能意义
Brain Res. 2003 Apr 18;969(1-2):135-46. doi: 10.1016/s0006-8993(03)02291-1.
4
Enhancing aromatic L-amino acid decarboxylase activity: implications for L-DOPA treatment in Parkinson's disease.增强芳香族L-氨基酸脱羧酶活性:对帕金森病左旋多巴治疗的意义。
CNS Neurosci Ther. 2008 Winter;14(4):340-51. doi: 10.1111/j.1755-5949.2008.00058.x.
5
L-Dihydroxyphenylalanine modulates the steady-state expression of mouse striatal tyrosine hydroxylase, aromatic L-amino acid decarboxylase, dopamine and its metabolites in an MPTP mouse model of Parkinson's disease.L-二羟苯丙氨酸调节 MPTP 帕金森病小鼠模型中鼠纹状体酪氨酸羟化酶、芳香族 L-氨基酸脱羧酶、多巴胺及其代谢物的稳态表达。
Life Sci. 2011 Oct 24;89(17-18):638-43. doi: 10.1016/j.lfs.2011.08.008. Epub 2011 Aug 18.
6
The localization and functional contribution of striatal aromatic L-amino acid decarboxylase to L-3,4-dihydroxyphenylalanine decarboxylation in rodent parkinsonian models.纹状体芳香族L-氨基酸脱羧酶在啮齿类帕金森病模型中对L-3,4-二羟基苯丙氨酸脱羧作用的定位及功能贡献。
Cell Transplant. 2000 Sep-Oct;9(5):567-76. doi: 10.1177/096368970000900502.
7
Aromatic L-amino acid decarboxylase immunoreactive cells in the rat striatum: a possible site for the conversion of exogenous L-DOPA to dopamine.大鼠纹状体中芳香族L-氨基酸脱羧酶免疫反应性细胞:外源性左旋多巴转化为多巴胺的可能位点。
Brain Res. 1995 Dec 15;704(1):51-60. doi: 10.1016/0006-8993(95)01104-8.
8
The site of dopamine formation in rat striatum after L-dopa administration.左旋多巴给药后大鼠纹状体中多巴胺的形成部位。
J Pharmacol Exp Ther. 1981 Apr;217(1):189-97.
9
L-3,4-Dihydroxyphenylalanine and L-5-hydroxytryptophan decarboxylase activities in rat striatum: effect of selective destruction of dopaminergic or serotoninergic input.大鼠纹状体中L-3,4-二羟基苯丙氨酸和L-5-羟色氨酸脱羧酶活性:多巴胺能或5-羟色胺能输入选择性破坏的影响
J Neurochem. 1980 Jun;34(6):1753-6. doi: 10.1111/j.1471-4159.1980.tb11270.x.
10
Decarboxylation of exogenous L-DOPA in rat striatum after lesions of the dopaminergic nigrostriatal neurons: the role of striatal capillaries.多巴胺能黑质纹状体神经元损伤后大鼠纹状体内外源性左旋多巴的脱羧作用:纹状体毛细血管的作用。
Brain Res. 1980 Sep 29;198(1):244-8. doi: 10.1016/0006-8993(80)90363-7.

引用本文的文献

1
Deuterium-substituted L-DOPA displays increased behavioral potency and dopamine output in an animal model of Parkinson's disease: comparison with the effects produced by L-DOPA and an MAO-B inhibitor.氘取代的左旋多巴在帕金森病动物模型中显示出增强的行为效力和多巴胺输出:与左旋多巴和单胺氧化酶B抑制剂产生的效果比较。
J Neural Transm (Vienna). 2015 Feb;122(2):259-72. doi: 10.1007/s00702-014-1247-6. Epub 2014 Jun 7.
2
IPX066: a new intermediate-and extended-release carbidopa-levodopa formulation.IPX066:一种新型的卡比多巴-左旋多巴缓释制剂。
Neurodegener Dis Manag. 2013 Apr 1;3(2):123-131. doi: 10.2217/nmt.13.4.
3
Understanding and prevention of "therapy-" induced dyskinesias.
理解和预防“治疗-”引起的运动障碍。
Parkinsons Dis. 2012;2012:640815. doi: 10.1155/2012/640815. Epub 2012 May 23.
4
Impact of endurance exercise on levodopa-associated cortisol release and force increase in patients with Parkinson's disease.耐力运动对帕金森病患者左旋多巴相关皮质醇释放及力量增加的影响。
J Neural Transm (Vienna). 2008 Jun;115(6):851-5. doi: 10.1007/s00702-008-0018-7. Epub 2008 Mar 12.
5
Acute levodopa administration reduces cortisol release in patients with Parkinson's disease.急性给予左旋多巴可降低帕金森病患者的皮质醇释放。
J Neural Transm (Vienna). 2007 Mar;114(3):347-50. doi: 10.1007/s00702-006-0552-0. Epub 2006 Aug 24.
6
Role of dopamine in learning and memory: implications for the treatment of cognitive dysfunction in patients with Parkinson's disease.多巴胺在学习和记忆中的作用:对帕金森病患者认知功能障碍治疗的启示。
Drugs Aging. 2000 May;16(5):365-79. doi: 10.2165/00002512-200016050-00006.
7
Characterization of intrastriatal recombinant adeno-associated virus-mediated gene transfer of human tyrosine hydroxylase and human GTP-cyclohydrolase I in a rat model of Parkinson's disease.帕金森病大鼠模型中纹状体内重组腺相关病毒介导的人酪氨酸羟化酶和人GTP-环化水解酶I基因转移的特征
J Neurosci. 1998 Jun 1;18(11):4271-84. doi: 10.1523/JNEUROSCI.18-11-04271.1998.
8
Selective inhibition of monoamine oxidase type B by MDL 72145 increases the central effects of L-dopa without modifying its cardiovascular effects.MDL 72145对单胺氧化酶B型的选择性抑制作用可增强左旋多巴的中枢效应,而不改变其心血管效应。
Br J Pharmacol. 1986 Jan;87(1):257-64. doi: 10.1111/j.1476-5381.1986.tb10179.x.
9
Levodopa peripheral pharmacokinetics and duration of motor response in Parkinson's disease.帕金森病中左旋多巴的外周药代动力学及运动反应持续时间
J Neurol Neurosurg Psychiatry. 1989 Jun;52(6):718-23. doi: 10.1136/jnnp.52.6.718.
10
Brain kinetics of L-[beta-11C]dopa in humans studied by positron emission tomography.通过正电子发射断层扫描研究人体中L-[β-11C]多巴的脑动力学。
J Neural Transm Gen Sect. 1991;86(1):25-41. doi: 10.1007/BF01250373.